Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Conditions
Small Cell Lung Cancer Extensive Stage
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Rocky Mountain Cancer Centers, LLP, Lone Tree, Colorado, United States
Contact: Principal Investigator (Robert M Jotte, MD)Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Contact: Study coordinator (Medical Oncology Clinical Call Center) · MedicalOncologyClinicalCallCenter@dom.wustl.edu · 314-747-1171Contact: Principal Investigator (Daniel Morgensztern, MD)Gabrail Cancer Center Research, Canton, Ohio, United States
Contact: Principal Investigator (Nashat Gabrail, MD)Oncology_Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States
Contact: Principal Investigator (David M Waterhouse, MD)Oncology_Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States
Contact: Principal Investigator (David M Waterhouse, MD)Oncology_Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States
Contact: Principal Investigator (David M Waterhouse, MD)Oncology_Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States
Contact: Principal Investigator (David M Waterhouse, MD)Oncology_Hematology Care Clinical Trials, LLC, Fairfield, Ohio, United States
Contact: Principal Investigator (David M Waterhouse, MD)Willamette Valley Cancer Institute (Oregon), Eugene, Oregon, United States
Contact: Principal Investigator (Bo Wang, MD)Northwest Cancer Specialists, P.C., Portland, Oregon, United States
Contact: Principal Investigator (Anthony Van Ho, MD)Providence Cancer Institute, Portland, Oregon, United States
Contact: Principal Investigator (Rachel Sanborn, MD)Northwest Cancer Specialists, P.C., Portland, Oregon, United States
Contact: Principal Investigator (Anthony Van Ho, MD)Northwest Cancer Specialists, P.C., Tigard, Oregon, United States
Contact: Principal Investigator (Anthony Van Ho, MD)Texas Oncology - DFW, Dallas, Texas, United States
Contact: Principal Investigator (Kartik Konduri, MD)Texas Oncology - Northeast Texas, Tyler, Texas, United States
Contact: Principal Investigator (Donald A Richards, MD)Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander I Spira, MD)Northwest Cancer Specialists, P.C., Vancouver, Washington, United States
Study leads
Mark S Berger, MD
Study Director
Genprex, Inc.